These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20853140)

  • 1. Semi-high throughput method of measuring proteasome inhibition in vitro and in cultured cells.
    Keyomarsi K; Efuet ET; Bui TN
    Cell Biol Toxicol; 2011 Apr; 27(2):123-31. PubMed ID: 20853140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S beta5-subunit.
    Blackburn C; Gigstad KM; Hales P; Garcia K; Jones M; Bruzzese FJ; Barrett C; Liu JX; Soucy TA; Sappal DS; Bump N; Olhava EJ; Fleming P; Dick LR; Tsu C; Sintchak MD; Blank JL
    Biochem J; 2010 Sep; 430(3):461-76. PubMed ID: 20632995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of proteasome inhibitors with different chemical structures on the ubiquitin-proteasome system in vitro.
    Csizmadia V; Csizmadia E; Silverman L; Simpson C; Raczynski A; O'Brien L; Gallacher M; Cardoza K; Kadambi VJ; Fedyk ER; Alden CL
    Vet Pathol; 2010 Mar; 47(2):358-67. PubMed ID: 20124009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of noncompetitive proteasome inhibition on bortezomib resistance.
    Li X; Wood TE; Sprangers R; Jansen G; Franke NE; Mao X; Wang X; Zhang Y; Verbrugge SE; Adomat H; Li ZH; Trudel S; Chen C; Religa TL; Jamal N; Messner H; Cloos J; Rose DR; Navon A; Guns E; Batey RA; Kay LE; Schimmer AD
    J Natl Cancer Inst; 2010 Jul; 102(14):1069-82. PubMed ID: 20505154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of a proteasome in Pneumocystis carinii and its modulation by specific proteasome inhibitors.
    Tronconi E; Mazza F; Valerio A; Rinaudo MT; Piccinini M; Anselmino A; Cargnel A; Atzori C
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S142-3. PubMed ID: 17169035
    [No Abstract]   [Full Text] [Related]  

  • 6. BU-32: a novel proteasome inhibitor for breast cancer.
    Agyin JK; Santhamma B; Nair HB; Roy SS; Tekmal RR
    Breast Cancer Res; 2009; 11(5):R74. PubMed ID: 19821999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the proteasome pathway.
    Tsukamoto S; Yokosawa H
    Expert Opin Ther Targets; 2009 May; 13(5):605-21. PubMed ID: 19397479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin-proteasome system stress sensitizes ovarian cancer to proteasome inhibitor-induced apoptosis.
    Bazzaro M; Lee MK; Zoso A; Stirling WL; Santillan A; Shih IeM; Roden RB
    Cancer Res; 2006 Apr; 66(7):3754-63. PubMed ID: 16585202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative selectivity and specificity of the proteasome inhibitors BzLLLCOCHO, PS-341, and MG-132.
    Crawford LJ; Walker B; Ovaa H; Chauhan D; Anderson KC; Morris TC; Irvine AE
    Cancer Res; 2006 Jun; 66(12):6379-86. PubMed ID: 16778216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasome inhibition represses ERalpha gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancer.
    Powers GL; Ellison-Zelski SJ; Casa AJ; Lee AV; Alarid ET
    Oncogene; 2010 Mar; 29(10):1509-18. PubMed ID: 19946334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition.
    An WG; Hwang SG; Trepel JB; Blagosklonny MV
    Leukemia; 2000 Jul; 14(7):1276-83. PubMed ID: 10914553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasomal chymotrypsin-like peptidase activity is required for essential functions of human monocyte-derived dendritic cells.
    Naujokat C; Berges C; Höh A; Wieczorek H; Fuchs D; Ovens J; Miltz M; Sadeghi M; Opelz G; Daniel V
    Immunology; 2007 Jan; 120(1):120-32. PubMed ID: 17083604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple cardiac proteasome subtypes differ in their susceptibility to proteasome inhibitors.
    Kloss A; Meiners S; Ludwig A; Dahlmann B
    Cardiovasc Res; 2010 Jan; 85(2):367-75. PubMed ID: 19564153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural compounds with proteasome inhibitory activity for cancer prevention and treatment.
    Yang H; Landis-Piwowar KR; Chen D; Milacic V; Dou QP
    Curr Protein Pept Sci; 2008 Jun; 9(3):227-39. PubMed ID: 18537678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential apoptotic response to the proteasome inhibitor Bortezomib [VELCADE, PS-341] in Bax-deficient and p21-deficient colon cancer cells.
    Yu J; Tiwari S; Steiner P; Zhang L
    Cancer Biol Ther; 2003; 2(6):694-9. PubMed ID: 14688479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ubiquitin-proteasome system plays an important role during various stages of the coronavirus infection cycle.
    Raaben M; Posthuma CC; Verheije MH; te Lintelo EG; Kikkert M; Drijfhout JW; Snijder EJ; Rottier PJ; de Haan CA
    J Virol; 2010 Aug; 84(15):7869-79. PubMed ID: 20484504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cells adapted to the proteasome inhibitor 4-hydroxy- 5-iodo-3-nitrophenylacetyl-Leu-Leu-leucinal-vinyl sulfone require enzymatically active proteasomes for continued survival.
    Princiotta MF; Schubert U; Chen W; Bennink JR; Myung J; Crews CM; Yewdell JW
    Proc Natl Acad Sci U S A; 2001 Jan; 98(2):513-8. PubMed ID: 11149939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of biochemical and biological effects of ML858 (salinosporamide A) and bortezomib.
    Williamson MJ; Blank JL; Bruzzese FJ; Cao Y; Daniels JS; Dick LR; Labutti J; Mazzola AM; Patil AD; Reimer CL; Solomon MS; Stirling M; Tian Y; Tsu CA; Weatherhead GS; Zhang JX; Rolfe M
    Mol Cancer Ther; 2006 Dec; 5(12):3052-61. PubMed ID: 17172407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells.
    Zhu K; Dunner K; McConkey DJ
    Oncogene; 2010 Jan; 29(3):451-62. PubMed ID: 19881538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of proteasome inhibitors on endotoxin-induced diaphragm dysfunction.
    Supinski GS; Vanags J; Callahan LA
    Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L994-L1001. PubMed ID: 19376888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.